DXB 2.83% 54.5¢ dimerix limited

Ann: Dimerix Plans for Next Study in Diabetic Kidney Disease, page-3

  1. 300 Posts.
    lightbulb Created with Sketch. 72
    yeah, this is such a shame

    how in the world is this all they have after 4 months
    their data analysis has always been underwhelming
    i honestly felt there was potential with the drug in the correct subgroup, but after seeing management performance (or lack there of), i couldnt stay in

    the cap raise is gonna be huge with this on top of FSGS since no indication of any partnership
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
54.5¢
Change
0.015(2.83%)
Mkt cap ! $299.6M
Open High Low Value Volume
53.0¢ 54.5¢ 52.0¢ $905.8K 1.698M

Buyers (Bids)

No. Vol. Price($)
1 8606 53.5¢
 

Sellers (Offers)

Price($) Vol. No.
54.5¢ 72714 5
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.